Hanson L A, Ahlstedt S, Fasth A, Jodal U, Kaijser B, Larsson P, Lindberg U, Olling S, Sohl-Akerlund A, Svanborg-Edén C
J Infect Dis. 1977 Aug;136 Suppl:S144-9. doi: 10.1093/infdis/136.supplement.s144.
Acute pyelonephritis (but not cystitis or "asymptomatic" bacteriuria) due to Escherichia coli induces serum antibodies to O-but rarely to K-antigens, especially not to the most common antigen, K1. Locally produced secretory IgA and IgG antibodies to O-and K-antigens appear in urine during most infections. The E. coli in urine of patients with asymptomatic bacteriuria are different from those in patients with acute pyelonephritis and cystitis and undergo continuous changes, presumably caused by the local antibody response. The E. coli become less virulent and are less able to attach to uroepithelial cells than E. coli causing acute symptomatic infections. Antibodies in urine prevent epithelial adherence. Parenteral and intravesicular injections of killed bacteria can protect against ascending pyelonephritis in rats. A few K-antigens dominate among E. coli that cause urinary tract infections. Vaccination of problem cases is a possibility because of the protective nature of K-antibodies. The mechanism of renal scarring that appears in some patients with urinary tract infections is unknown. Autoantibodies to the Tamm-Horsfall protein that increase after acute pyelonephritis or the cross-reactions noted between certain E. coli and antigens on the kidney may be involved.
由大肠杆菌引起的急性肾盂肾炎(而非膀胱炎或“无症状”菌尿症)可诱导机体产生针对O抗原的血清抗体,但很少产生针对K抗原的抗体,尤其是针对最常见的抗原K1。在大多数感染过程中,尿液中会出现针对O抗原和K抗原的局部产生的分泌型IgA和IgG抗体。无症状菌尿症患者尿液中的大肠杆菌与急性肾盂肾炎和膀胱炎患者尿液中的大肠杆菌不同,且会持续变化,推测这是由局部抗体反应引起的。与导致急性症状性感染的大肠杆菌相比,无症状菌尿症患者尿液中的大肠杆菌毒力降低,黏附于尿路上皮细胞的能力也减弱。尿液中的抗体可阻止细菌黏附。给大鼠进行皮下和膀胱内注射灭活细菌可预防上行性肾盂肾炎。在引起尿路感染的大肠杆菌中,少数K抗原占主导地位。鉴于K抗体具有保护性,可以考虑对问题病例进行疫苗接种。一些尿路感染患者出现肾瘢痕形成的机制尚不清楚。急性肾盂肾炎后增加的针对Tamm-Horsfall蛋白的自身抗体或某些大肠杆菌与肾脏抗原之间的交叉反应可能与之有关。